Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) (Details Textual)

v3.5.0.2
Stockholders' Equity (Deficit) (Details Textual) - USD ($)
 1 Months Ended 7 Months Ended 9 Months Ended
Jul. 31, 2016
Sep. 30, 2015
Sep. 30, 2016
Jul. 26, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common Stock, Shares Authorized 50,000,000   50,000,000 2,000,000 50,000,000
Common Stock, Par or Stated Value Per Share $ 0.0001   $ 0.0001   $ 0.0001
Proceeds from Issuance or Sale of Equity   $ 0 $ 11,083,000    
Payments for Underwriting Expense     $ 1,400,000    
Warrant [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock Issued During Period, Shares, New Issues     478,708    
General and Administrative Expense [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Allocated Share-based Compensation Expense     $ 274,000    
Common Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock Issued During Period, Shares, New Issues     1,914,833    
Convertible Common Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Conversion of Stock, Shares Issued 7,000,000        
Series A Preferred Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common Stock, Shares Authorized       250,000  
Stock Issued During Period, Shares, New Issues     0    
Conversion of Stock, Shares Issued 250,000        
Common Class B [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock Issued During Period, Shares, New Issues     0    
Conversion of Stock, Shares Converted 7,250,000        
Common Class A [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common Stock, Shares Authorized 1,000,000        
Stock Issued During Period, Shares, New Issues     0    
Fortress Biotech, Inc [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares Of Common Stock,Percentage     2.50%    
Fortress Biotech, Inc [Member] | Common Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock Issued During Period, Shares, New Issues     47,870    
Private Placement [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Warrant Purchase Price Per Unit     $ 65,000    
Warrant Expiration Term     5 years    
Warrants Issued     191,483    
Stock Issued During Period, Shares, New Issues     10,000    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     2,500    
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 8.50    
Payments for Underwriting Expense     $ 1,300,000    
Private Placement [Member] | National Holdings Corporation [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage Of Placement Agent Fee     10.00%    
Percentage Of Shares Issued To Placement Agent     10.00%